Yiwei Sun

Yiwei Sun

Auto-generated profile, based on publicly available information

Yiwei Sun

Department of Systems Biology, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2023 in Nature Biotechnology
Verified
Journal Article
Open access
PDF file
YHYiming Huang
Yiming Huang
RSRavi U Sheth
Ravi U Sheth
SZShijie Zhao
Shijie Zhao
LCLucas A. Cohen
Lucas A. Cohen
KDKendall Dabaghi
Kendall Dabaghi
HWHarris H. Wang
Harris H. Wang
Pure bacterial cultures remain essential for detailed experimental and mechanistic studies in microbiome research, and traditional methods to isolate individual bacteria from complex microbial ecosystems are labor-intensive, difficult-to-scale and lack phenotype–genotype integration. Here we describe an open-source high-throughput robotic strain isolation platform for the rapid generation of isolates on demand. We develop a machine learning approach that leverages colony morphology and genomic data to maximize the diversity of microbes isolated and enable targeted picking of specific genera. Application of this platform on fecal samples from 20 humans yields personalized gut microbiome biobanks totaling 26,997 isolates that represented >80% of all abundant taxa. Spatial analysis on >100,000 visually captured colonies reveals cogrowth patterns between Ruminococcaceae, Bacteroidaceae, Coriobacteriaceae and Bifidobacteriaceae families that suggest important microbial interactions. Comparative analysis of 1,197 high-quality genomes from these biobanks shows interesting intra- and interpersonal strain evolution, selection and horizontal gene transfer. This culturomics framework should empower new research efforts to systematize the collection and quantitative analysis of imaging-based phenotypes with high-resolution genomics data for many emerging microbiome studies.

22 March 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
EYEi-Wen Yang
Ei-Wen Yang
JBJae Hoon Bahn
Jae Hoon Bahn
EHEsther Yun-Hua Hsiao
Esther Yun-Hua Hsiao
BTBoon Xin Tan
Boon Xin Tan
YSYiwei Sun
Yiwei Sun
XXXinshu Xiao
Xinshu Xiao
Allele-specific protein-RNA binding is an essential aspect that may reveal functional genetic variants (GVs) mediating post-transcriptional regulation. Recently, genome-wide detection of in vivo binding of RNA-binding proteins is greatly facilitated by the enhanced crosslinking and immunoprecipitation (eCLIP) method. We developed a new computational approach, called BEAPR, to identify allele-specific binding (ASB) events in eCLIP-Seq data. BEAPR takes into account crosslinking-induced sequence propensity and variations between replicated experiments. Using simulated and actual data, we show that BEAPR largely outperforms often-used count analysis methods. Importantly, BEAPR overcomes the inherent overdispersion problem of these methods. Complemented by experimental validations, we demonstrate that the application of BEAPR to ENCODE eCLIP-Seq data of 154 proteins helps to predict functional GVs that alter splicing or mRNA abundance. Moreover, many GVs with ASB patterns have known disease relevance. Overall, BEAPR is an effective method that helps to address the outstanding challenge of functional interpretation of GVs.

24 April 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ZLZhaoqi Liu
Zhaoqi Liu
JZJian Zhang
Jian Zhang
YSYiwei Sun
Yiwei Sun
TPTomin E. Perea-Chamblee
Tomin E. Perea-Chamblee
JMJames L. Manley
James L. Manley
RRRaul Rabadan
Raul Rabadan
Significance: SF3B1 is the most commonly mutated splicing factor in cancers, and SF3B1 mutations result in aberrant 3′ splice site usage during splicing of a subset of introns. Here, we utilized an unbiased computational biology approach to determine whether cancer-associated mutations in any other genes produce the same pattern of aberrant splicing as do SF3B1 mutations. We found that, while rare, the most frequently mutated gene that causes such splicing defects is SUGP1 . This is striking because previous biochemical studies indicated that loss of SF3B1 interaction with SUGP1 underlies the effects of SF3B1 mutations on splicing. Our findings thus establish the cancer relevance of the biochemical link between SF3B1 and SUGP1 and also identify SUGP1 as a cancer-associated gene.

4 January 2021 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
BLBo Liu
Bo Liu
ZLZhaoqi Liu
Zhaoqi Liu
SCSisi Chen
Sisi Chen
MKMichelle Ki
Michelle Ki
CECaroline Erickson
Caroline Erickson
SCSarat Chandarlapaty
Sarat Chandarlapaty
Mutations in the core RNA splicing factor SF3B1 are prevalent in leukemias and uveal melanoma, but hotspot SF3B1 mutations are also seen in epithelial malignancies such as breast cancer. Although hotspot mutations in SF3B1 alter hematopoietic differentiation, whether SF3B1 mutations contribute to epithelial cancer development and progression is unknown. Here, we identify that SF3B1 mutations in mammary epithelial and breast cancer cells induce a recurrent pattern of aberrant splicing leading to activation of AKT and NF-κB, enhanced cell migration, and accelerated tumorigenesis. Transcriptomic analysis of human cancer specimens, MMTV-cre Sf3b1K700E/WT mice, and isogenic mutant cell lines identified hundreds of aberrant 3′ splice sites (3′ss) induced by mutant SF3B1. Consistently between mouse and human tumors, mutant SF3B1 promoted aberrant splicing (dependent on aberrant branchpoints as well as pyrimidines downstream of the cryptic 3′ss) and consequent suppression of PPP2R5A and MAP3K7, critical negative regulators of AKT and NF-κB. Coordinate activation of NF-κB and AKT signaling was observed in the knockin models, leading to accelerated cell migration and tumor development in combination with mutant PIK3CA but also hypersensitizing cells to AKT kinase inhibitors. These data identify hotspot mutations in SF3B1 as an important contributor to breast tumorigenesis and reveal unique vulnerabilities in cancers harboring them.

13 November 2025 in Science
Verified
Journal Article
Closed access
DGDiego Rivera Gelsinger
Diego Rivera Gelsinger
CRCarlotta Ronda
Carlotta Ronda
JMJunjie Ma
Junjie Ma
OKOm B. Kar
Om B. Kar
MEMadeline Edwards
Madeline Edwards
HWHarris H. Wang
Harris H. Wang
Although metagenomic sequencing has revealed a rich microbial biodiversity in the mammalian gut, methods to genetically alter specific species in the microbiome are highly limited. Here, we introduce Metagenomic Editing (MetaEdit) as a platform technology for microbiome engineering that uses optimized CRISPR-associated transposases delivered by a broadly conjugative vector to directly modify diverse native commensal bacteria from mice and humans with new pathways at single-nucleotide genomic resolution. Using MetaEdit, we achieved in vivo genetic capture of native murine Bacteroides by integrating a metabolic payload that enables tunable growth control in the mammalian gut with dietary inulin. We further show in vivo editing of segmented filamentous bacteria, an immunomodulatory small-intestinal microbial species recalcitrant to cultivation. Collectively, this work provides a paradigm to precisely manipulate individual bacteria in native communities across gigabases of their metagenomic repertoire.

31 August 2022 in Clinical and Translational Gastroenterology
Verified
Journal Article
Open access
JBJohn W. Blackett
John W. Blackett
YSYiwei Sun
Yiwei Sun
LPLawrence Purpura
Lawrence Purpura
KMKara Gross Margolis
Kara Gross Margolis
MEMitchell Elkind
Mitchell Elkind
DFDaniel E. Freedberg
Daniel E. Freedberg
INTRODUCTION: An estimated 15%–29% of patients report new gastrointestinal (GI) symptoms after coronavirus-19 disease (COVID-19) while 4%–31% report new depressive symptoms. These symptoms may be secondary to gut microbiome tryptophan metabolism and 5-hydroxytryptamine (5-HT)-based signaling. METHODS: This study used specimens from 2 patient cohorts: (i) fecal samples from patients with acute COVID-19 who participated in a randomized controlled trial testing prebiotic fiber and (ii) blood samples from patients with acute COVID-19. Six months after recovering from COVID-19, both cohorts answered questions related to GI symptoms and anxiety or depression. Microbiome composition and function, focusing on tryptophan metabolism-associated pathways, and plasma 5-HT were assessed. RESULTS: In the first cohort (n = 13), gut microbiome L-tryptophan biosynthesis during acute COVID-19 was decreased among those who developed more severe GI symptoms (2.0-fold lower log activity comparing those with the most severe GI symptoms vs those with no symptoms, P = 0.06). All tryptophan pathways showed decreased activity among those with more GI symptoms. The same pathways were also decreased in those with the most severe mental health symptoms after COVID-19. In an untargeted analysis, 5 additional metabolic pathways significantly differed based on subsequent development of GI symptoms. In the second cohort (n = 39), plasma 5-HT concentration at the time of COVID-19 was increased 5.1-fold in those with GI symptoms alone compared with those with mental health symptoms alone (P = 0.02). DISCUSSION: Acute gut microbiome-mediated reduction in 5-HT signaling may contribute to long-term GI and mental health symptoms after COVID-19. Future studies should explore modification of 5-HT signaling to reduce post-COVID symptoms.